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Lysophosphatidic acid (LPA) is one of the main membrane-derived lysophospholipids,
inducing diverse cellular responses like cell proliferation, cell death inhibition, and
cytoskeletal rearrangement, and thus is important in many biological processes. In the
central nervous system (CNS), post-mitotic neurons release LPA extracellularly whereas
astrocytes do not. Astrocytes play a key role in brain development and pathology,
producing various cytokines, chemokines, growth factors, and extracellular matrix (ECM)
components that act as molecular coordinators of neuron–glia communication. However,
many molecular mechanisms underlying these events remain unclear—in particular, how
the multifaceted interplay between the signaling pathways regulated by lysophospholipids
is integrated in the complex nature of the CNS. Previously we showed that LPA-primed
astrocytes induce neuronal commitment by activating LPA1–LPA2 receptors. Further, we
revealed that these events were mediated by modulation and organization of laminin
levels by astrocytes, through the induction of the epidermal growth factor receptor (EGFR)
signaling pathway and the activation of the mitogen-activated protein (MAP) kinase (MAPK)
cascade in response to LPA (Spohr et al., 2008, 2011). In the present work, we aimed
to answer whether LPA affects astrocytic production and rearrangement of fibronectin,
and to investigate the mechanisms involved in neuronal differentiation and maturation
of cortical neurons induced by LPA-primed astrocytes. We show that PKA activation is
required for LPA-primed astrocytes to induce neurite outgrowth and neuronal maturation
and to rearrange and enhance the production of fibronectin and laminin. We propose a
potential mechanism by which neurons and astrocytes communicate, as well as how such
interactions drive cellular events such as neurite outgrowth, cell fate commitment, and
maturation.
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INTRODUCTION
Lysophospholipids (LPs) are not only structural components
of cellular membranes but also biologically active molecules.
LPs were initially identified as precursors and metabolites of de
novo biosynthesis of phospholipids. However, it was subsequently
observed that they have properties similar to those of extra-
cellular growth factors or signaling molecules, influencing pro-
Abbreviations: BSA, bovine serum albumin; C-CM, conditioned medium of
control astrocytes; CNS, central nervous system; DMEM, Dulbecco’s modified
Eagle’s medium; E 14, embryos at day 14; ECM, extracellular matrix proteins;
EGF, epidermal growth factor; FAFBSA, fatty acid free bovine serum albumin;
LPA, lysophosphatidic acid; LPA1–LPA5, the five LPA receptor subtypes;
LPA-CM, conditioned medium of LPA-treated astrocytes; LPAR, lysophos-
phatidic acid receptors; MAPK, mitogen-activated protein (MAP) kinase;
PBS, phosphate saline buffer; PKA, protein kinase A; PVDF, polyvinylidene
difluoride; S1P, sphingosine 1-phospate; SDS-PAGE, sodium dodecyl sulfate-
polyacrylamide gel; TBS-T, tris saline buffer with tween.
cesses such as carcinogenesis, neurogenesis, immunity, vascular
development, or regulation of metabolic diseases. Lysophospho-
lipids act through specific G protein-coupled receptors in an
autocrine or paracrine fashion (for review see Ishii et al., 2004;
Grzelczyk and Gendaszewska-Darmach, 2013).
Lysophosphatidic acid (LPA) is one of the main membrane-
derived LPs. Lysophosphatidic acid signaling properties are medi-
ated by at least six G protein-coupled receptors, referred to
as LPAR1–LPAR5 and P2Y5 (Gardell et al., 2006; Choi et al.,
2010). Lysophosphatidic acid-induced cellular responses include
cell proliferation, cell death inhibition, and cytoskeletal rear-
rangement, which play important roles in many biological
processes such as oncogenesis, wound healing, immune func-
tions, and especially brain development (Anliker and Chun,
2004; Choi et al., 2010). Lysophosphatidic acid receptors are
expressed in subsets of cells in the developing and mature rodent
nervous system and play key functions in its morphogenesis
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and homeostasis (Choi et al., 2010). In the central nervous
system (CNS), post-mitotic neurons release LPA extracellularly
(Fukushima et al., 2000) whereas astrocytes do not (Spohr et al.,
2008).
Astrocytes, the most abundant glial cells, play a key role in
brain development and pathology, producing various cytokines,
chemokines, growth factors, and extracellular matrix (ECM)
components which act as molecular coordinators of neuron–
glia communication (Yuan et al., 1997; Sloan and Barres, 2014).
Moreover, they have been shown to be potential stem cells in the
developing or in the adult brain (Kriegstein and Alvarez-Buylla,
2009), to influence neuronal fate and growth-cone navigation
(Wislet-Gendebien et al., 2005; Spohr et al., 2008; Dezonne et al.,
2013), to modify the number of synaptic connections (Ishige
et al., 2001), and to control synapse formation and function
(Shi and Massague, 2003; Corbin et al., 2008; Allen et al., 2012;
Diniz et al., 2012). Because astrocytes express all five LPA classic
receptors (LPA1–5; Spohr et al., 2008; Noguchi et al., 2009), they
are potential targets for LPA actions on neuronal tissue.
Much is known about neuron–glia interactions and their role
in CNS development, neuronal differentiation, and axonal out-
growth (De Bock et al., 2014; Sloan and Barres, 2014). However,
many molecular mechanisms underlying these events remain
unclear—in particular, how the multifaceted interplay between
the signaling pathways regulated by lysophospholipids is inte-
grated in the complex nature of the CNS.
We previously described how astrocytes treated with LPA
induce neuronal differentiation and neurite outgrowth of cortical
neurons. These events are mediated by a soluble factor secreted by
astrocytes and able to induce the epidermal growth factor (EGF)
signaling pathway, activate mitogen-activated protein (MAP)
kinase (MAPK), and rearrange the astrocyte laminin ECM (Spohr
et al., 2008, 2011). Indeed, it is well known that ECM proteins,
such as laminin and fibronectin, play a key role in neuronal
differentiation and regeneration, neurite elongation, neuronal
migration, proper axonal projection, and synaptogenesis (Carri
et al., 1988; Chamak and Prochiantz, 1989; Nakashima et al., 1999;
Nat et al., 2007).
It is still unknown whether LPA affects the production and
rearrangement of fibronectin by astrocytes and if so, how this
process affects neuronal differentiation and maturation of cortical
neurons. In the present work we aimed to answer these questions,
and accordingly investigated the mechanisms involved in these
processes. Here, we report for the first time that LPA-primed
astrocytes affect fibronectin levels and deposition by activating
protein kinase A (PKA) signaling pathways in response to LPA.
Our data provide new insights on the role of astrocytes as
inductors of neuronal fate commitment and neurite outgrowth,
associated with PKA pathway activation in treated astrocytes.
MATERIAL AND METHODS
ASTROCYTE PRIMARY CULTURES
Animals were obtained from the Animal Facility of the Institute
of Biomedical Sciences of the Federal University of Rio de Janeiro.
All animal protocols were approved by the Animal Research
Committee of the Federal University of Rio de Janeiro (DAHEICB
024). Astrocyte primary cultures were prepared from the cerebral
cortex of newborn Swiss mice, as previously described (Spohr
et al., 2008). Briefly, after the mice were anesthetized, they were
decapitated, the brain structures were removed, and the meninges
were carefully stripped off. Tissues were washed in phosphate-
buffered saline (PBS) with 0.6% glucose (Sigma Chemical Co., St.
Louis, MO, USA) and dissociated into single cells in a medium
consisting of Dulbecco’s minimum essential medium (DMEM)
and nutrient mixture F12 (DMEM/F12; Invitrogen, Rockville,
MD, USA), enriched with glucose (3.3 × 10−2 M), glutamine
(2 × 10−3 M), and sodium bicarbonate (0.3 × 10−2 M). Dis-
sociated cells were plated onto glass coverslips on a 24-well
plate (Corning Incorporated, NY, USA), previously coated with
poly-L-lysine (Sigma Chemical Co.), in DMEM/F12 medium
supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad,
CA, USA). The cultures were incubated at 37◦C in a humid-
ified 5% CO2, 95% air chamber for 7–10 days until reaching
confluence.
LPA TREATMENT AND CONDITIONED MEDIUM PREPARATION
After reaching confluence, glial monolayers were washed three
times with serum-free DMEM/F12 medium and incubated as
previously described for an additional day in this medium.
After this period, the cultures were treated with 1 µM LPA
(Spohr et al., 2011) (Avanti Polar Lipids, Alabaster, AL, USA)
in DMEM/F12 supplemented with 0.1% fatty-acid-free bovine
serum albumin (FAFBSA, Sigma Chemical Co.) for 4 h. Control
astrocyte carpets were treated with DMEM/F12 supplemented
with 0.1% FAFBSA. Then, the glial monolayers were washed
with serum-free DMEM/F12 medium, and the medium was
replaced by DMEM/F12 without serum and used as the substrate
in neural progenitor–astrocyte assays. For astrocyte conditioned
medium preparation, after the astrocyte monolayers were treated
with LPA-FAFBSA or FAFBSA, the medium was replaced by
DMEM-F12 and the cultures were then maintained for an addi-
tional day. Conditioned medium (CM) derived from either LPA-
treated astrocytes (LPA-CM) or conditioned medium of control
astrocytes (C-CM) was recovered, centrifuged at 1500 g for 10
min, and used immediately or stored in aliquots at −70◦C for
further use.
NEURAL PROGENITOR–ASTROCYTE CO-CULTURE ASSAYS
For cortical progenitor cultures, female Swiss mice were killed by
ether followed by cervical dislocation, and embryos were removed
at day 14 (E14). Cortical progenitors were prepared from the
cerebral cortex of E14 embryos as previously described (Spohr
et al., 2008). Briefly, cells were freshly dissociated from the cerebral
cortex and 5 × 104 cells were plated onto glial monolayer carpets
that were either not treated or were previously treated with LPA
for 4 h or 300 µL of LPA-CM, as previously described. In the
case of LPA-CM assays, the medium was not replaced after 4 h
of treatment; instead, it was left until the end of the co-culture.
The co-cultures were kept for 24 h at 37◦C in a humidified 5%
CO2, 95% air atmosphere.
NEURAL PROGENITOR CULTURES
Progenitor cells were prepared from cortex derived from 14-day
Swiss mice embryos, as described above. Briefly, cells were freshly
dissociated from the cerebral cortex, and 1× 105 cells were plated
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onto glass coverslips previously coated with poly-L-lysine (Sigma
Chemical Co.) in astrocyte-conditioned medium. The cultures
were kept for 24 h at 37◦C in a humidified 5% CO2, 95% air
atmosphere (Spohr et al., 2011).
PKA INHIBITION ASSAYS
For PKA inhibition assays, the PKA inhibitor KT5720 was
used. Astrocyte monolayers were concomitantly treated with
LPA (1 µM) and specific signaling pathway inhibitors KT5720
(400 nM) for 4 h according to the previously described protocol.
After the treatment, embryonic precursors (E14) were plated onto
the treated astrocyte carpets and co-cultures were kept at 37◦C in
a humidified 5% CO2, 95% air atmosphere for 24 h. The inhibitor
was purchased from Calbiochem (Gibbstown, NJ) and diluted in
methyl sulfoxide (C2H6OS, Sigma Chemical Co., St. Louis, MO).
IMMUNOCYTOCHEMISTRY
Immunocytochemistry was performed as previously described
(Spohr et al., 2011). Briefly, cultured cells were fixed with 4%
paraformaldehyde for 30 min and permeabilized with 0.2% Triton
X-100 for 5 min at 24◦C. After permeabilization, the cells were
blocked with 5% bovine serum albumin (BSA) (Sigma Chemical
Co.) in PBS (blocking solution) for 1 h and incubated overnight
at 4◦C with specified primary antibodies diluted in blocking
solution. Primary antibodies were mouse anti-β-tubulin III anti-
body (Promega Corporation, Madison, WI, USA; 1:1000), rabbit
anti-fibronectin (Sigma Chemical Co., 1:100), and rabbit anti-
laminin (Sigma Chemical Co., 1:100). After primary antibody
incubation, cells were extensively washed with PBS and incu-
bated with secondary antibodies for 1 h, at 24◦C. The secondary
antibodies were goat anti-mouse IgG conjugated with alexa fluor
488 (Molecular Probes, Eugene, OR, USA; 1:500) and goat anti-
rabbit IgG conjugated with alexa fluor 546 (Molecular Probes,
1:500). Negative controls were performed by omitting the primary
antibody during staining. In all cases, no reactivity was observed
when the primary antibody was absent. Cell preparations were
mounted directly on n-propyl gallate (Sigma Chemical Co.) and
visualized using a Nikon microscope.
IMMUNOBLOTTING ASSAYS
Protein concentration in cell extracts (CE) was measured in
triplicate with the BCA™ Protein Assay kit (Cole-Parmer Canada
Inc., Montreal, QC, Canada). Fifty micrograms of protein per
lane were electrophoretically-separated in 8–15% gradient (for
ECM proteins) sodium dodecyl sulfate–polyacrylamide gel. After
separation, the proteins were electrically transferred to a Hybond-
P polyvinylidene difluoride (PVDF) transfer membrane (Amer-
sham Biosciences, Little Chalfont, Buckinghamshire, UK) for 3 h.
Membranes were blocked overnight in Tris-buffered saline-Tween
20 (Merck, Darmstadt, Germany) containing 10% BSA. Then,
primary antibodies diluted in block solution were added for
2 h at 24◦C. After several washes in Tris-buffered saline-Tween
20, peroxidase-conjugated secondary antibodies diluted in block
solution were added to the membrane and incubated for 2 h
at 24◦C. Proteins were visualized using the enhancing chemi-
luminescence detection system (Super Signal West Pico Chemi-
luminescent Substrate; Pierce Biotechnology, Milwaukee, WI,
USA), and polyvinylidene difluoride membranes were exposed
to autoradiographic films. Primary antibodies were mouse anti-
α-tubulin (Sigma Chemical Co., 1:5000), rabbit anti-fibronectin
(Sigma Chemical Co., 1:500) and rabbit anti-laminin (Sigma
Chemical Co., 1:500). Secondary peroxidase-conjugated antibod-
ies were goat anti-rabbit IgG and goat anti-mouse IgG (Amer-
sham Biosciences, 1:5000).
QUANTITATIVE ANALYSIS
To determine cell density, neuron number, and neurite out-
growth, the co-cultures were immunostained with the antibody
against the neuronal marker β-tubulin III (Promega Corporation,
1:1000) and visualized and counted using a Nikon microscope.
Neurite length was assessed by measuring the distance from one
cell body to the end of all neurites, in which the final length was
considered the sum of all neurites measured from this one cell
body. We also measured the longest neurite by measuring only
the distance from one cell body to the end of the longest neurite.
At least 10 fields were measured per well. In all cases, at least 100
randomly chosen neurons were observed per well (Spohr et al.,
2011). The experiments were done in triplicate, and each result
represents the mean of three independent experiments. Statisti-
cal analyses included a Student’s t-test and a one-way ANOVA,
followed by a Tukey’s Multiple Comparison Test. Densitometry
of the immunocytochemistry images and the blotting gels was
performed using the Image J 1.40 g program (National Institutes
of Health, USA).
RESULTS
LPA-PRIMED ASTROCYTES INDUCE FIBRONECTIN REARRANGEMENT
To investigate whether fibronectin ECM was modulated by astro-
cytes, we treated it with LPA for 4 h or with LPA-CM for
24 h. After 24 h, these cultures were fixed and immunostained
for fibronectin (Figure 1). Both LPA and LPA-CM significantly
affected fibronectin rearrangement compared to control con-
ditions (Figures 1A–D). In addition, LPA- or LPA-CM-treated
astrocytes increased fibronectin protein by 70% and 118%,
respectively, as measured by immunolabeling densitometry
(Figure 1E) or by 67% and 17%, respectively, as measured by
Western blot (Figures 1F,G). These data suggest that LPA modu-
lates fibronectin rearrangement by stimulating astrocytes through
direct or indirect mechanisms.
LPA-PRIMED ASTROCYTES INDUCE NEURONAL DIFFERENTIATION AND
MATURATION BY PKA PATHWAY ACTIVATION
The signaling pathways of LPA receptors recruit different G
proteins, which in turn activate various downstream effec-
tors such as Rho, Ras/MAPkinase, and phospholipase C
(Panetti et al., 2001). Thus, the response to LPA is deter-
mined by which pathway is activated. Cyclic AMP (cAMP)
controls many cellular processes, mainly through the activa-
tion of PKA, such as integrin-mediated cell adhesion (Ribatti,
2007).
We questioned whether PKA is involved in neurite outgrowth
and is induced in LPA-primed astrocytes. To this end, astrocyte
monolayers were treated for 4 h concomitantly with LPA and the
specific PKA inhibitor KT5720. To prevent a direct action of the
drug on neurons rather than a glia-mediated effect, inhibitor-
containing medium was replaced by drug-free medium before
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FIGURE 1 | LPA-primed astrocytes modulate astrocyte levels of ECM
proteins in vitro. After confluence, astrocytes were treated for 4 h with
FAF-BSA (A) or 1 µM LPA (B), or control conditioned medium (C-CM) (C), or
conditioned medium derived from LPA-treated astrocytes (LPA-CM) (D) for
24 h. Then the cells were fixed and immunostained for the ECM protein
fibronectin (A–D). We observed an increase in the levels and a difference in
the deposition pattern of fibronectin expressed by the astrocytes when they
were treated with LPA and LPA-CM (A–E). The levels of fibronectin per
micrograph were analyzed in ImageJ (percentage of control). Representative
Western blots and graphic analysis were done from three independent
experiments. After treatment of astrocytes, equal amounts of total protein
(50 µg per lane) from astrocytes treated with LPA (F) were analyzed by
immunoblotting for fibronectin. Immune reaction for α-tubulin was used to
monitor the loading. The levels of fibronectin protein immunoreactivity are
expressed relative to the levels observed in cultures of astrocytes treated
with FAF-BSA (control astrocytes). For (E, G), * p < 0.05. Error bar
corresponds to SEM. All quantifications were made at least three times.
Scale bars correspond to 20 µm.
neuronal plating; after 24 h, the cells were stained for β-tubulin
III (Figures 2A–C). After 24 h, we observed an increase of 44%
in the neuronal population plated onto LPA-primed astrocytes
(Figures 2B,D). In addition, morphological analysis revealed a
marked increase in the number of processes per neuron plated
onto LPA-primed astrocytes, with an overall increase of those
neurons showing two or more neurites (Figure 2E). Cells were
grouped according to the number of processes extending from
a single soma. LPA-primed astrocytes decreased the number
of aneuritic neurons relative to control cultures (Figure 2E).
However, inhibition of PKA reverted LPA-induced neuronal
differentiation, neuritogenesis, and neurite outgrowth to those
observed in the control conditions (Figures 2D–F). Most neu-
rons plated onto astrocytes treated with PKA inhibitor devel-
oped neurites with average size between 50 and 100 µm, which
was similar to the neurons under control conditions. On the
other hand, neurons plated onto LPA-primed astrocytes exhibited
an average size between 100 and 200 µm (Figure 2G). Thus,
PKA is required for LPA-primed astrocyte-induced neuronal
maturation.
PKA PATHWAY IS NECESSARY IN LPA-PRIMED ASTROCYTES FOR
FIBRONECTIN AND LAMININ PROTEIN DEPOSITION AND
REARRANGEMENT
Because LPA-primed astrocytes induce neuronal differentiation
and maturation by PKA activation, we investigated if fibronectin
deposition was associated with PKA activation. To evaluate this
question, astrocyte monolayers were simultaneously treated with
LPA and KT5720 for 4 h. Fibronectin rearrangement was analyzed
by immunostaining and fibronectin production by Western blot
(Figures 3A–F). Immunostaining densitometry results suggest
that the PKA inhibitor KT5720 reverted LPA-induced fibronectin
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FIGURE 2 | LPA-treated astrocytes induce neuronal differentiation
through PKA signaling pathway. Cortical progenitors obtained from E14
mice were cultured for 24 h on control astrocytes (A) or LPA-treated
astrocytes alone (B) and simultaneously with PKA inhibitor KT5720 (LPA + KT;
C). Cells were fixed and immunostained for the neuronal marker β-tubulin III
(β tub III). Addition of PKA-specific inhibitor totally abolished the effect of LPA
on neuronal differentiation (D), arborization (E) and neurite outgrowth (F and
G). Statistical significance was observed for all columns (0, 1, 2, 3, or +
neurites) between control–LPA and LPA–LPA + KT (p < 0.05). Total neurite
length (F and G) was obtained using the ImageJ Software (National Institutes
of Health, USA). In all cases, at least 100 randomly chosen neurons were
observed. All quantifications were made at least 3 times. For (D) and (F),
* p < 0.05; error bars correspond to SEM. Scale bar corresponds
to 30 µm.
rearrangement to control levels (Figure 3D). Further, KT5720
also reduced LPA-induced total fibronectin production by astro-
cytes to the levels observed under control conditions (Figure 3F).
We also observed that PKA inhibition abolished laminin
rearrangement and total production in LPA-primed astrocytes
(Figures 4A–F). This was shown either by immunostaining den-
sitometry (Figure 4D) or Western blot (Figure 4F). Thus, PKA
activation is required for LPA-primed astrocytes to induce neu-
rite outgrowth and neuronal maturation and to rearrange and
enhance the production of fibronectin and laminin.
DISCUSSION
In the present work, we investigated whether LPA stimulates
astrocytes to rearrange and produce fibronectin and, if so, how
this process affects neuronal differentiation and maturation.
Furthermore, we explored whether a similar mechanism is
employed by laminin.
Our previous studies using LPA1–LPA2 knockout mice showed
that LPA-primed astrocytes induce neuronal commitment by
activating both of these receptors in astrocytes (Spohr et al., 2008).
Further, we revealed that these events were mediated by modula-
tion and organization of laminin levels by astrocytes, through the
induction of the epidermal growth factor receptor (EGFR) signal-
ing pathway and the activation of the MAPK cascade in response
to LPA (Spohr et al., 2011). The results presented here suggest that
the PKA signaling pathway and fibronectin are also important for
LPA-primed astrocytes to induce neuronal maturation. Because
the PKA pathway is activated, it is possible that the LPA receptor
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FIGURE 3 | PKA specific inhibitor totally abolished the effect of LPA on
fibronectin levels. After confluence, astrocytes were treated for 4 h with
FAF-BSA (A) or 1 µM LPA (B), or simultaneously with PKA specific inhibitor
KT5720 (C). After 24 h, the cells were fixed and immunostained for FN (A–C).
KT5720 abolished the effect of LPA on FN protein levels, (A–F).
Representative Western blots and graphic analysis of three independent
experiments showing FN protein levels (E). Immune reaction for α-tubulin
was used to monitor loading. KT5720 abolished LPA effects on FN levels (k).
For (D, F), *p < 0.05; error bars correspond to SEM. Scale bar corresponds to
20 µm.
isoform LPAR4 is also involved in this process (Gardell et al.,
2006).
Fibronectin and other ECM proteins have been shown to influ-
ence neurite outgrowth (Chamak and Prochiantz, 1989; Garcia-
Abreu et al., 1995; Martinez and Gomes, 2002; Guizzetti et al.,
2008; Plantman et al., 2008), axonal guidance (Webber et al.,
2008), differentiation (Ma et al., 2008; Sun et al., 2008), and cell
proliferation (Wang and Milner, 2006; Lathia et al., 2007).
It is already known that LPA enhances binding and modulates
the assembly of fibronectin on the surface of non-neural cells
(Zhang et al., 1994). This is the first report to show that LPA
modulates fibronectin rearrangement and production in the ner-
vous system. Because PKA inhibition in LPA-primed astrocytes
also abolished the effects of neuronal commitment and neurite
outgrowth, it is plausible that fibronectin plays a key role in this
event. In a previous study from our group, we described that EGF
induces neurite outgrowth of cerebellar neurons by modulating
the content of laminin and fibronectin on the astrocyte surface,
thus enhancing cerebellar neuritogenesis in vitro (Martinez and
Gomes, 2002). However, in this study we were not able to
establish a direct correlation between the two events in cortical
astrocytes.
Fibronectin is an important ECM protein that participates in
cellular adhesion, spreading, and migration of diverse cell types
(Trentin et al., 2003), whereas laminin helps in neurite out-
growth as an adhesive substrate (Garcia-Abreu et al., 1995; Spohr
et al., 2011). Modulation of these two ECM proteins is therefore
important for normal CNS development. Other molecules such as
guanosine 5′-monophosphate and guanosine have been shown to
activate PKA and other signaling effectors such as MAPK, protein
kinase II, Ca2+-calmodulin and protein kinase C, in order to reor-
ganize ECM proteins (Decker et al., 2007). Here we also observed
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FIGURE 4 | PKA specific inhibitor totally abolished the effect of LPA on
laminin levels. After confluence, astrocytes were treated for 4 h with
FAF-BSA (A) or 1 µM LPA (B), or simultaneously with PKA specific inhibitor
KT5720 (C). After 24 h, the cells were fixed and immunostained for laminin
(A–C). KT5720 abolished the effect of LPA on LN protein levels (A–D).
Representative Western blots and graphic analysis of three independent
experiments showing LN protein levels (E). Immune reaction for α-tubulin
was used to monitor loading. KT5720 abolished LPA effects on LN levels (F).
For (D), (F), * p < 0.05; error bars correspond to SEM. Scale bar corresponds
to 20 µm.
that PKA signaling is important for fibronectin and laminin
production and rearrangement in LPA-primed astrocytes.
Interestingly, LPA is not the only lysophospholipid able to
modulate ECM proteins and neuronal maturation. Recently
we showed that shingosine-1 phosphate (S1P) increased and
modified the pattern of astrocytic laminin production to pro-
mote neuronal differentiation of neural progenitor cells (Spohr
et al., 2012). We observed that S1P-primed astrocytes also
affect fibronectin rearrangement and production (data not
shown).
LPA induces several cellular responses, depending on the
cell type, the receptor subtype, and the effector pathway stim-
ulated (Choi et al., 2010). In cultured astrocytes, LPA treat-
ment induces intracellular Ca2+ mobilization, production of
reactive oxygen species, and DNA synthesis, and also inhibits
glutamate uptake (Tabuchi et al., 2000; Bergers and Benjamin,
2003; Spits et al., 2008). In addition, LPA treatment also induces
morphological changes, stabilization of astrocyte stress fibers,
and stimulates actomyosin contraction through a Rho-mediated
pathway (Breier, 2000; Weaver et al., 2007). Further, PKA and
RhoA activation are involved in cellular migration induced by LPA
(Hirakawa et al., 2007). Also, LPA and αβ and β integrins act in
concert to activate Rac1, RhoA, PKA, and PI3K to promote cell
polarization and motility (O’Connor et al., 2012). Thus, besides
PKA and MAPK, one can speculate that Rac1, RhoA, and Phos-
phoinositide 3-kinase also play a role in the downstream signaling
events triggered by LPA, which culminate in astrocyte-induced
neuronal maturation and fibronectin organization. However, fur-
ther studies will be necessary to address this hypothesis.
Over the last decade, the neurosciences have gone through
a paradigm change, due to accumulating evidence that glial
cells, especially astrocytes, are key players in brain development
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FIGURE 5 | Schematic model of the indirect effects on neural precursor
cells mediated by LPA-primed astrocytes. Extracellular LPA, possibly
secreted by post-mitotic neurons (1), acts on cortical astrocytes and (2)
induces secretion of EGF ligands (EGF and/or TGF-α) and activated MAPK
and PKA signaling pathways in these cells (3) thus yielding production of
ECM proteins (laminin and fibronectin) (4). These events lead to neuronal
precursor differentiation and axonal growth (5).
and pathology (Gomes et al., 2001; De Bock et al., 2014;
Sloan and Barres, 2014). Indeed, these cells may act as
stem cells, either during development or in the adult brain
(Kriegstein and Alvarez-Buylla, 2009), and control synapse
formation and function (Diniz et al., 2012). Here we propose a
potential mechanism by which neurons and astrocytes commu-
nicate, as well as how such interactions drive cellular events such
as neurite outgrowth, cell fate commitment, and maturation. In
summary, we suggest that post-mitotic neuronal extracellular
LPA acts on astrocytes, which in turn secrete EGF ligands (EGF
and/or TGF-α), activate MAPK and PKA pathways, and modulate
fibronectin and laminin rearrangement and production (Spohr
et al., 2011; Figure 5). These events are important to support
neuronal precursor differentiation and neurite outgrowth medi-
ated by LPA-primed astrocytes (Spohr et al., 2008, 2011). Future
efforts should investigate the possibility of using this bioactive
lipid as a therapeutic tool for axon regeneration and CNS
repair.
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